Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Focus on Europe

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 28 May 2004:
Vol. 304. no. 5675, pp. 1269 - 1273
DOI: 10.1126/science.1096725

Review

Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity

Judith L. Turgeon,1 Donald P. McDonnell,3 Kathryn A. Martin,4 Phyllis M. Wise2

The results of the Women's Health Initiative, a study anticipated to provide definitive answers about health benefits and risks of postmenopausal hormone therapy, have generated debate and confusion among clinicians, researchers, and the lay public. The ovarian hormones estrogen and progesterone, which decline at menopause, normally elicit complex tissue-specific responses throughout the body. Major advances are providing a detailed molecular definition of how that differential action is achieved. Here we review estrogen and progestin actions, discuss how effectively knowledge of steroid hormone endocrinology has been incorporated into clinical studies, and consider the impact on modern hormone therapy protocols and pharmaceutical development.

1 Department of Internal Medicine, Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, University of California–Davis, Davis, CA 95616, USA.
2 Department of Neurobiology, Physiology and Behavior, Division of Biological Sciences, University of California–Davis, Davis, CA 95616, USA.
3 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
4 Harvard Medical School, Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.

* To whom correspondence should be addressed. E-mail: jlturgeon{at}ucdavis.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Vascular Actions of Estrogens: Functional Implications.
V. M. Miller and S. P. Duckles (2008)
Pharmacol. Rev. 60, 210-241
   Abstract »    Full Text »    PDF »
Growth Factor Regulation of Estrogen Receptor Coregulator PELP1 Functions via Protein Kinase A Pathway.
J. K. Nagpal, S. Nair, D. Chakravarty, R. Rajhans, S. Pothana, D. W. Brann, R. R. Tekmal, and R. K. Vadlamudi (2008)
Mol. Cancer Res. 6, 851-861
   Abstract »    Full Text »    PDF »
Hormone Therapy, Dilemmas, Medical Decisions..
J. Schulkin (2008)
J. Law Med. Ethics 36, 73-88
   PDF »
17{beta}-Estradiol: a novel hormone for improving immune and cardiovascular responses following trauma-hemorrhage.
M. A. Choudhry and I. H. Chaudry (2008)
J. Leukoc. Biol. 83, 518-522
   Abstract »    Full Text »    PDF »
Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression.
K. L. Hamilton, L. Lin, Y. Wang, and A. A. Knowlton (2008)
Physiol Genomics 32, 254-263
   Abstract »    Full Text »    PDF »
Perimenopausal Depression.
B. L. Parry (2008)
Am J Psychiatry 165, 23-27
   Full Text »    PDF »
Estrogen and Comprehension of Metaphoric Speech in Women Suffering From Schizophrenia: Results of a Double-Blind, Placebo-Controlled Trial.
N. Bergemann, P. Parzer, S. Jaggy, B. Auler, C. Mundt, and S. Maier-Braunleder (2007)
Schizophr Bull
   Abstract »    Full Text »    PDF »
Changes in Adiponectin and Inflammatory Genes in Response to Hormonal Imbalances in Female Mice and Exacerbation of Depot Selective Visceral Adiposity by High-Fat Diet: Implications for Insulin Resistance.
H. Zhang, X. Chen, J. Aravindakshan, and M. R. Sairam (2007)
Endocrinology 148, 5667-5679
   Abstract »    Full Text »    PDF »
Effects of estrogens and selective estrogen receptor modulators on vascular reactivity in the perfused mesenteric vascular bed.
C. J. Mark, R. Tatchum-Talom, D. S. Martin, and K. M. Eyster (2007)
Am J Physiol Regulatory Integrative Comp Physiol 293, R1969-R1975
   Abstract »    Full Text »    PDF »
Coactivators PGC-1beta and SRC-1 Interact Functionally to Promote the Agonist Activity of the Selective Estrogen Receptor Modulator Tamoxifen.
D. Kressler, M. B. Hock, and A. Kralli (2007)
J. Biol. Chem. 282, 26897-26907
   Abstract »    Full Text »    PDF »
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System.
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu (2007)
Endocr. Rev. 28, 387-439
   Abstract »    Full Text »    PDF »
Differential Effects of 17{beta}-Estradiol on Function and Expression of Estrogen Receptor {alpha}, Estrogen Receptor {beta}, and GPR30 in Arteries and Veins of Patients With Atherosclerosis.
E. Haas, M. R. Meyer, U. Schurr, I. Bhattacharya, R. Minotti, H. H. Nguyen, A. Heigl, M. Lachat, M. Genoni, and M. Barton (2007)
Hypertension 49, 1358-1363
   Abstract »    Full Text »    PDF »
Normalization of hormonal imbalances, ovarian follicular dynamics and metabolic effects in follitrophin receptor knockout mice.
R. Tiwari-Pandey, Y. Yang, J. Aravindakshan, and M.R. Sairam (2007)
Mol. Hum. Reprod. 13, 287-297
   Abstract »    Full Text »    PDF »
Age alters cerebrovascular inflammation and effects of estrogen.
L. Sunday, C. Osuna, D. N. Krause, and S. P. Duckles (2007)
Am J Physiol Heart Circ Physiol 292, H2333-H2340
   Abstract »    Full Text »    PDF »
Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions.
S. Suzuki, C. M. Brown, C. D. Dela Cruz, E. Yang, D. A. Bridwell, and P. M. Wise (2007)
PNAS 104, 6013-6018
   Abstract »    Full Text »    PDF »
Oral Contraceptives, Reproductive Factors, and Risk of Colorectal Cancer among Women in a Prospective Cohort Study.
J. Lin, S. M. Zhang, N. R. Cook, J. E. Manson, J. E. Buring, and I-M. Lee (2007)
Am. J. Epidemiol. 165, 794-801
   Abstract »    Full Text »    PDF »
Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently.
V. H. Huxley (2007)
Advan Physiol Educ 31, 17-22
   Abstract »    Full Text »    PDF »
Sex-based differences in physiology: what should we teach in the medical curriculum?.
M. L. Blair (2007)
Advan Physiol Educ 31, 23-25
   Abstract »    Full Text »    PDF »
Suppression of {beta}-Amyloid Precursor Protein Signaling into the Nucleus by Estrogens Mediated through Complex Formation between the Estrogen Receptor and Fe65.
J. Bao, C. Cao, X. Zhang, F. Jiang, S. V. Nicosia, and W. Bai (2007)
Mol. Cell. Biol. 27, 1321-1333
   Abstract »    Full Text »    PDF »
Role of Pituitary Hormones on 17{alpha}-Ethinylestradiol-Induced Cholestasis in Rat.
L. A. Henriquez-Hernandez, A. Flores-Morales, R. Santana-Farre, M. Axelson, P. Nilsson, G. Norstedt, and L. Fernandez-Perez (2007)
J. Pharmacol. Exp. Ther. 320, 695-705
   Abstract »    Full Text »    PDF »
Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability.
J. Benton, A. Powers, L. Eiselein, R. Fitch, D. Wilson, A. C. Villablanca, and J. C. Rutledge (2007)
Am J Physiol Regulatory Integrative Comp Physiol 292, R723-R730
   Abstract »    Full Text »    PDF »
NM23-H2, an estrogen receptor beta-associated protein, shows diminished expression with progression of atherosclerosis.
K. Rayner, Y.-X. Chen, B. Hibbert, D. White, H. Miller, E. H. Postel, and E. R. O'Brien (2007)
Am J Physiol Regulatory Integrative Comp Physiol 292, R743-R750
   Abstract »    Full Text »    PDF »
Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis.
T. Bupha-Intr, J. Wattanapermpool, J. R. Pena, B. M. Wolska, and R. J. Solaro (2007)
Am J Physiol Regulatory Integrative Comp Physiol 292, R837-R843
   Abstract »    Full Text »    PDF »
Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women.
J. H. Morrison, R. D. Brinton, P. J. Schmidt, and A. C. Gore (2006)
J. Neurosci. 26, 10332-10348
   Full Text »    PDF »
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies.
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise (2006)
Endocr. Rev. 27, 575-605
   Abstract »    Full Text »    PDF »
Attenuation of Mitogen- and Stress-Activated Protein Kinase-1-Driven Nuclear Factor-{kappa}B Gene Expression by Soy Isoflavones Does Not Require Estrogenic Activity..
W. Vanden Berghe, N. Dijsselbloem, L. Vermeulen, M. N. Ndlovu, E. Boone, and G. Haegeman (2006)
Cancer Res. 66, 4852-4862
   Abstract »    Full Text »    PDF »
The Endogenous Estrogen Status Regulates Microglia Reactivity in Animal Models of Neuroinflammation.
E. Vegeto, S. Belcredito, S. Ghisletti, C. Meda, S. Etteri, and A. Maggi (2006)
Endocrinology 147, 2263-2272
   Abstract »    Full Text »    PDF »
Estrogen Alters Spine Number and Morphology in Prefrontal Cortex of Aged Female Rhesus Monkeys.
J. Hao, P. R. Rapp, A. E. Leffler, S. R. Leffler, W. G. M. Janssen, W. Lou, H. McKay, J. A. Roberts, S. L. Wearne, P. R. Hof, et al. (2006)
J. Neurosci. 26, 2571-2578
   Abstract »    Full Text »    PDF »
Estrogen Receptor {alpha} Mediates Acute Potassium Channel Stimulation in Human Coronary Artery Smooth Muscle Cells.
G. Han, X. Yu, L. Lu, S. Li, H. Ma, S. Zhu, X. Cui, and R. E. White (2006)
J. Pharmacol. Exp. Ther. 316, 1025-1030
   Abstract »    Full Text »    PDF »
Estrogen and mitochondria: a new paradigm for vascular protection?.
S. P. Duckles, D. N. Krause, C. Stirone, and V. Procaccio (2006)
Mol. Interv. 6, 26-35
   Abstract »    Full Text »    PDF »
Estrogen Receptor {alpha} Gene Polymorphisms Are Associated with the Angiographic Extent of Coronary Artery Disease.
A. Rokach, A. Pollak, L. Rosen, Y. Friedlander, A. Blumenfeld, L. Reznik, and R. Dresner-Pollak (2005)
J. Clin. Endocrinol. Metab. 90, 6556-6560
   Abstract »    Full Text »    PDF »
Gender Differences in the Endotoxin-Induced Inflammatory and Vascular Responses: Potential Role of Poly(ADP-ribose) Polymerase Activation.
J. G. Mabley, E. M. Horvath, K. G. K. Murthy, Z. Zsengeller, A. Vaslin, R. Benko, M. Kollai, and C. Szabo (2005)
J. Pharmacol. Exp. Ther. 315, 812-820
   Abstract »    Full Text »    PDF »
Estrogen Selectively Promotes the Differentiation of Dendritic Cells with Characteristics of Langerhans Cells.
A. Mao, V. Paharkova-Vatchkova, J. Hardy, M. M. Miller, and S. Kovats (2005)
J. Immunol. 175, 5146-5151
   Abstract »    Full Text »    PDF »
Conformational dynamics of estrogen receptors {alpha} and {beta} as revealed by intrinsic tryptophan fluorescence and circular dichroism.
S K Nair, T J Thomas, N J Greenfield, A Chen, H He, and T Thomas (2005)
J. Mol. Endocrinol. 35, 211-223
   Abstract »    Full Text »    PDF »
Estrogen Increases Mitochondrial Efficiency and Reduces Oxidative Stress in Cerebral Blood Vessels.
C. Stirone, S. P. Duckles, D. N. Krause, and V. Procaccio (2005)
Mol. Pharmacol. 68, 959-965
   Abstract »    Full Text »    PDF »
Estrogen Inhibits Cardiomyocyte Hypertrophy in Vitro: ANTAGONISM OF CALCINEURIN-RELATED HYPERTROPHY THROUGH INDUCTION OF MCIP1.
A. Pedram, M. Razandi, M. Aitkenhead, and E. R. Levin (2005)
J. Biol. Chem. 280, 26339-26348
   Abstract »    Full Text »    PDF »
Molecular and Cellular Basis of Cardiovascular Gender Differences.
M. E. Mendelsohn and R. H. Karas (2005)
Science 308, 1583-1587
   Abstract »    Full Text »    PDF »
The Longevity Gender Gap: Are Telomeres the Explanation?.
A. Aviv, J. Shay, K. Christensen, and W. Wright (2005)
Sci. Aging Knowl. Environ. 2005, pe16
   Abstract »    Full Text »
Role of Nonfeminizing Estrogens in Brain Protection from Cerebral Ischemia: An Animal Model of Alzheimer's Disease Neuropathology.
J. W. SIMPKINS, Y. WEN, E. PEREZ, S. YANG, and X. WANG (2005)
Ann. N.Y. Acad. Sci. 1052, 233-242
   Abstract »    Full Text »    PDF »
Impact of Metabolism on the Safety of Estrogen Therapy.
K. PROKAI-TATRAI and L. PROKAI (2005)
Ann. N.Y. Acad. Sci. 1052, 243-257
   Abstract »    Full Text »    PDF »
Embodiment: a conceptual glossary for epidemiology.
N. Krieger (2005)
J. Epidemiol. Community Health 59, 350-355
   Abstract »    Full Text »    PDF »
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).
K. M. Wasan, P. E. Goss, P. H. Pritchard, L. Shepherd, M. J. Palmer, S. Liu, D. Tu, J. N. Ingle, M. Heath, D. DeAngelis, et al. (2005)
Ann. Onc. 16, 707-715
   Abstract »    Full Text »    PDF »
A Randomized Placebo-Controlled Trial of Short-Term Graded Transdermal Estradiol in Healthy Gonadotropin-Releasing Hormone Agonist-Suppressed Pre- and Postmenopausal Women: Effects on Serum Markers of Bone Turnover, Insulin-Like Growth Factor-I, and Osteoclastogenic Mediators.
P. Y. Liu, K. A. Hoey, K. L. Mielke, J. D. Veldhuis, and S. Khosla (2005)
J. Clin. Endocrinol. Metab. 90, 1953-1960
   Abstract »    Full Text »    PDF »
Estradiol Regulates Susceptibility following Primary Exposure to Genital Herpes Simplex Virus Type 2, while Progesterone Induces Inflammation.
A. E. Gillgrass, S. A. Fernandez, K. L. Rosenthal, and C. Kaushic (2005)
J. Virol. 79, 3107-3116
   Abstract »    Full Text »    PDF »
Hair Cycle Control by Estrogens: Catagen Induction via Estrogen Receptor (ER)-{alpha} Is Checked by ER{beta} Signaling.
U. Ohnemus, M. Uenalan, F. Conrad, B. Handjiski, L. Mecklenburg, M. Nakamura, J. Inzunza, J.-A. Gustafsson, and R. Paus (2005)
Endocrinology 146, 1214-1225
   Abstract »    Full Text »    PDF »
Modulation of Estrogen Signaling by the Novel Interaction of Heat Shock Protein 27, a Biomarker for Atherosclerosis, and Estrogen Receptor {beta}: Mechanistic Insight Into the Vascular Effects of Estrogens.
H. Miller, S. Poon, B. Hibbert, K. Rayner, Y.-X. Chen, and E. R. O'Brien (2005)
Arterioscler. Thromb. Vasc. Biol. 25, e10-e14
   Abstract »    Full Text »    PDF »
Acute effects of 17{beta}-estradiol on myocardial pH, Na+, and Ca2+ and ischemia-reperfusion injury.
S. E. Anderson, D. M. Kirkland, A. Beyschau, and P. M. Cala (2005)
Am J Physiol Cell Physiol 288, C57-C64
   Abstract »    Full Text »    PDF »
Arzoxifene: A Promising New Selective Estrogen Receptor Modulator for Clinical Chemoprevention of Breast Cancer: Commentary re C. J. Fabian et al., Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator. Clin Cancer Res 2004;10:5403-17..
M. B. Sporn (2004)
Clin. Cancer Res. 10, 5313-5315
   Full Text »    PDF »
A New Slice of Pie?: Estrogen Regulation of Plasminogen Activator Inhibitor-1.
N. Madamanchi, X. Liu, and M. S. Runge (2004)
Circ. Res. 95, 228-229
   Full Text »    PDF »
Estrogen and Dementia: Insights From the Women's Health Initiative Memory Study.
L. S. Schneider (2004)
JAMA 291, 3005-3007
   Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)